Pancreas |
miR-375 |
Islet functions |
PDX1, HNF6, INSM1, Ngn3 |
[20,21] |
miR-15a/b, miR-16, miR-195 |
Islet functions |
Ngn3 |
[22] |
miR-7 |
Islet cells differentiation |
Pax6 |
[23,24] |
miR-96 |
Insulin secretion |
Stx-1α |
[25] |
miR-124a |
Insulin secretion |
Stx-1α |
[25] |
miR-124a |
Insulin release |
SNAP25, Rab3A, Synapin-1A, Rab27A, Noc2 |
[25] |
miR-124a |
Islet functions |
Foxa2, Pdx1, Creb1 |
[26] |
miR-9 |
Insulin secretion |
Stx-1α |
[25] |
miR-9 |
Insulin release |
Onecut-2, Granuphilin/slp4 |
[27] |
miR-29 |
Insulin secretion |
Stx-1α, Mct1 |
[28] |
miR-192-5p |
Islet β-cell functions |
Clock |
[29,30,31,32] |
miR-192-5p |
Insulin sensitivity |
CaV1 |
[29,30,31,32] |
miR-103, miR-107 |
Insulin sensitivity |
CaV1 |
[33] |
Liver |
miR-122 |
Liver functions |
LETFS, HNF6, HNF4a |
[34,35] |
miR-122 |
Lipid metabolism |
SREBF1 |
[34,35] |
miR-26a |
Lipid metabolism |
ACSL3, ACSL4, PKC, GSK3β, SREBF2 |
[36] |
miR-33b |
Lipid metabolism |
SREBF1 |
[37] |
miR-34a |
Fatty acid metabolism |
SIRT1 |
[38] |
miR-34a |
Lipid metabolism |
SREBP1 |
[38] |
miR-370 |
Lipid metabolism |
MECPT |
[39] |
miR-96, miR-183 |
Lipid metabolism |
SREBP |
[40] |
miR-30c |
Lipid metabolism |
RARB, LPGAT1, MTP |
[41,42,43,44] |
miR-30c |
Glucose metabolism |
IDH1, LIN28B |
[41,42,43,44] |
miR-192-5p |
De novo lipogenesis |
SREBF1, SCD-1 |
[30,31,32,33] |
miR-192-5p |
Inflammation |
FoxO1 |
[30,31,32,33] |
miR-192-5p |
Cholesterol homeostasis |
ABCG4 |
[30,31,32,33] |
miR-192-5p |
Lipid metabolism |
ElOVL1, ElOVL5, PPARA, VLDLR, FABP3, ATF1, CAV2, CRTc2, DBT, IGF1 |
[30,31,32,33] |
miR-33a-3p |
Cholesterol efflux |
ABCA1, ABCG1 |
[45] |
miR-33a-3p |
Insulin signaling |
IRS2, SIRT6 |
[45] |
miR-33a-3p |
Lipid metabolism |
SREBP2, SREBF1 |
[45] |
miR-223 |
Cholesterol efflux |
ABCA1 |
[45] |
miR-223 |
Cholesterol biosynthesis |
HMG-CoA, SC4MOL |
[46] |
miR-206 |
Lipid metabolism |
LXR2 |
[46] |
miR-200 |
Liver cell growth and proliferation |
PI3K |
[47] |
miR-27a-3p |
Cholesterol metabolism |
LDLRAP1, LRP6 |
[48,49,50,51] |
miR-27a-3p |
De novo lipogenesis |
SCD1, RXRα |
[48,49,50,51] |
miR-27a-3p |
Inflammation |
Nrf2, NF-κB |
[48,49,50,51] |
miR-27a-3p |
Lipid metabolism |
PPARA, FASN, SREBF1, FAS |
[48,49,50,51] |
miR-128 |
Cholesterol metabolism |
LDLR |
[52] |
miR-128 |
Cholesterol efflux |
ABCA1 |
[52] |
miR-128 |
Inflammation |
Nrf2 |
[52] |
miR-130b, miR-301b |
Cholesterol metabolism |
LDLR |
[53,54,55] |
miR-130b, miR-301b |
Cholesterol efflux |
ABCA1 |
[53,54,55] |
miR-27b |
Cholesterol efflux |
ABCA1 |
[48,49,50,51] |
miR-27b |
Lipid metabolism |
LDLR |
[48,49,50,51] |
miR-140-5p |
Cholesterol metabolism |
LDLR |
[10,55,56] |
miR-140-5p |
Inflammation |
Nrf2 |
[10,55,56] |
miR-140-5p |
AMPK/SREBP1 pathway |
NEAT1 |
[10,55,56] |
miR-2, miR-148a-3p, miR-185 |
Cholesterol metabolism |
LDLR |
[57,58] |
miR-2, miR-148a-3p, miR-185 |
Lipid metabolism |
SERBP2 |
[57,58] |
miR-21 |
Lipid metabolism |
HMGCR, HOMER1, Smad7 |
[59,60,61,62,63] |
miR-344 |
Lipid metabolism (Wnt/β-catenin signaling pathway) |
GSK3β |
[49] |
Muscle |
miR-29a |
IR |
PPARδ, |
[64] |
miR-29a |
Glucose uptake |
IRS-1 |
[65] |
miR-106b |
Mitochondrial dysfunction, IR |
mitofusin-2 |
[66] |
miR-208 |
Glucose metabolism |
MED13 |
[67,68] |
miR-199a-3p, miR-590-3p |
p/Akt pathway |
HOMER1, CLIC5 |
[55,58,69,70,71] |
AT |
miR-14 |
Lipid metabolism |
p38, MAPK |
[72] |
miR-143 |
Adipocyte differentiation |
ERK5 signaling |
[73] |
miR-27a, miR-130a |
Adipocyte differentiation |
PPARγ |
[55] |
miR-27b, miR-363 |
Adipocyte differentiation |
C/EBPα, PPARγ |
[74] |
Let-7 |
Cell functions |
RAS, HMGA2 |
[75,76,77] |
Let-7 |
Glucose metabolism |
INSR, IGF1R |
[75,76,77] |
Let-7 |
Adipogenesis |
AT-hook2, PPARγ, FABP4 |
[75,76,77] |
miR-375 |
Adipocyte differentiation |
C/EBPα, PPARγ2 |
[78] |
miR-206 |
Lipid accumulation |
PPARγ, PTEN, FAS, C/EBPα |
[79] |
miR-146b |
Metabolic homeostasis |
SIRT1 |
[80] |
miR-8 |
Adipogenesis |
FABP4 |
[47,81] |
miR-8 |
Fat body growth and differentiation |
PI3K |
[47,81] |
miR-210 |
Adipocyte differentiation (PI3K/Akt pathway) |
SHIPI |
[82] |
miR-21 |
Adipocyte differentiation |
AP-1, TGF-β receptor 2 |
[83] |
miR-30c |
Adipocyte differentiation |
SERPINE1, ACVR1 |
[41,42,43,44] |
miR-142-5p |
Inflammation |
Nrf2 |
[55,56,84] |
miR-26a |
Inflammation |
IL-6, IL-17 |
[78,85,86,87] |
miR-26a |
Autophagy |
BECN1, LC3 |
[78,85,86,87] |
miR-370 |
Metabolic homeostasis |
CPTIA |
[39] |
miR-22 |
Adipogenesis |
HDAC6 |
[88] |
miR-31 |
Lipid accumulation |
C/EBPα |
[89] |
miR-33b |
Lipogenesis |
EBF1 |
[37] |
miR-93 |
Adipogenesis |
Sirt7, Tbx3 |
[90] |
miR-125a |
Adipogenesis |
ERRα |
[91] |
miR-155 |
Adipocyte differentiation |
PPARγ |
[92] |
miR-145 |
Preadipocyte differentiation |
IRS1 |
[93] |
miR-155 |
Lipid metabolism |
C/EBPβ |
[94] |
miR-194 |
Stimulates osteogenesis and inhibits adipogenesis |
COUP-TFII |
[95] |
miR-224 |
Fatty acid metabolism |
EGR2 |
[96] |
miR-363 |
Adipocyte differentiation |
E2F3, C/EBPα, PPARγ |
[74] |
miR-369 |
Adipogenic differentiation |
FABP4 |
[97] |
miR-448 |
Lipid metabolism |
KLF5, 5-HT2AR, 5-HT2CR |
[98] |
miR-709 |
Lipid metabolism (Wnt/ß-catenin signaling) |
GSK3β |
[99] |
miR-637 |
Adipogenesis |
Sp7 |
[100] |
miR-320 |
Adipogenesis |
RUNX2 |
[101] |
miR-199a |
Adipogenesis |
Smad1 |
[70] |
miR-103 |
Adipogenesis (AKT/mTOR signal pathway) |
MEF2D |
[102] |
miR-26b |
Adipogenic differentiation |
PTEN |
[79,87] |